This content is machine translated An update Cochrane analysis compares eleven substances in MS The aim of a recent meta-analysis by the Cochrane Collaboration was to compare eleven agents used in relapsing-remitting multiple sclerosis (RRMS) in terms of reduction in relapse rates, disability progression,…
View Post 3 min This content is machine translated The epileptic seizure as stroke mimic The role of perfusion CT Introduction: The clinical distinction between a stroke and an epileptic seizure is not always easy in the emergency situation. However, for the indication of thrombolytic therapy, the distinction between these…
View Post 2 min This content is machine translated Goodbye The last – on our own account This number is very special for me. It is the last one for me as editor of InFo NEUROLOGIE & PSYCHIATRIE.
View Post 8 min This content is machine translated Differential diagnoses of multiple sclerosis How to track mimics The current diagnostic criteria for multiple sclerosis (MS) allow a very early and specific diagnosis in most cases. When MS is suspected, however, it is always important to consider the…
View Post 6 min This content is machine translated Stroke prevention in VHF Real-life data with dabigatran convincing For the first time, real-life data are available for one of the new oral anticoagulants. These were presented in Zurich on October 2, 2013. They demonstrate a compelling safety and…
View Post 2 min This content is machine translated On the farewell of Prof. Philippe Lyrer Partir, c’est mourir un peu Dear Philippe. Ten years ago, in the fall of 2003, we published the first issue of InFo NEUROLOGIE & PSYCHIATRIE together – you as the editor of Neurology, me as…
View Post 8 min This content is machine translated Immunotherapy and immunomodulation Disease-modifying therapies for multiple sclerosis. Multiple sclerosis is the most common neurological disease in young adults. Already at a young age it can lead to permanent disability, but the disease activity at the beginning of…
View Post 5 min This content is machine translated Rehabilitation and long-term management in MS Are rehabilitative measures still necessary in MS today? Despite the introduction of disease-modulating pharmacological therapies, rehabilitative interventions continue to play an important role in the long-term management of MS. People with MS should be encouraged to engage in…
View Post 4 min This content is machine translated New anticoagulants Questions of practical application are to be clarified The new anticoagulants rivaroxaban, apixaban, and dabigatran promise several benefits, but are not suitable for all patient populations. Various questions arise in primary care practice, which were discussed at this…
View Post 3 min This content is machine translated Swiss Heart Foundation 2.6 million Swiss francs for cardiac and cerebrovascular research The Swiss Heart Foundation supported cardiovascular research with around 2.6 million Swiss francs in 2014. This means that 44 applications will receive a grant and can be started.
View Post 5 min This content is machine translated Rivastigmine Dosage is critical with cholinesterase inhibitors Background: Alzheimer’s disease (AK) is the most common cause of dementia. The pathophysiology is complex and includes reductions in neurotransmitter release, leading to cognitive and functional impairment.
